## Abstract ## Background and Objectives Although studies have focused on modulating the bioavailability of 5โFU through inhibition of dihydropyrimidine dehydrogenase (DPD) to improve efficacy of the drug, activity of this enzyme in breast cancer has not been thoroughly examined. We measured DPD a
Increased phospholipase D activity in human breast cancer
โ Scribed by Nobuyuki Uchida; Shin-ichi Okamura; Yukio Nagamachi; Satoshi Yamashita
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 715 KB
- Volume
- 123
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Multidrug resistance (MDR) is a major cause of failure of cancer chemotherapy and is often associated with elevated expression of drug transporters such as P-glycoprotein (P-gp) in the cancer cells. MDR is, however, accompanied by additional biochemical changes including modifications of membrane co
Specific atypical histological patterns of epithelial hyperplasia (AH) indicate a medically relevant risk of breast cancer development in 5-10% of women with otherwise benign biopsies. This risk is about four times that of similar women, i.e., of the same age and at risk for the same length of time.